What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries - Sorbonne Université Accéder directement au contenu
Communication Dans Un Congrès Année : 2020

What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries

Domaines

Sciences du Vivant [q-bio]

Maryse Guerin  : Connectez-vous pour contacter le contributeur

https://hal.sorbonne-universite.fr/hal-03970175

Soumis le : jeudi 2 février 2023-16:04:43

Dernière modification le : jeudi 15 février 2024-15:00:09

Fichier non déposé

Dates et versions

hal-03970175 , version 1 (02-02-2023)

Identifiants

  • HAL Id : hal-03970175 , version 1

Citer

K Ray K, I Bridges, E Bruckert, B van Hout, M Sibartie, et al.. What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries. European-Society-of-Cardiology (ESC) Congress, Aug 2020, Amsterdam, Netherlands. ⟨hal-03970175⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE IHU_ICAN
3 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More